TABLE 2.
Change in outcomes following nut intervention compared to a control
| Outcome | Number of strata | Number of studies | Number of participants | Effect estimate | Inconsistency (I2)% |
|---|---|---|---|---|---|
| LDL cholesterol, mmol/L | 126 | 122 | 9487 | −0.11 (−0.14, −0.07), P < 0.00001 | 80 |
| HDL cholesterol, mmol/L | 126 | 122 | 10,102 | 0.00 (−0.01, 0.02), P = 0.59 | 81 |
| TC, mmol/L | 126 | 122 | 9423 | −0.13 (−0.18, −0.09), P < 0.00001 | 87 |
| TG, mmol/L | 122 | 118 | 9744 | −0.06 (−0.08, −0.03), P < 0.00001 | 61 |
| TG:HDL cholesterol | 5 | 5 | 331 | −0.12 (−0.40, 0.15), P = 0.37 | 0 |
| TC:HDL cholesterol | 51 | 49 | 3837 | −0.15 (−0.24, −0.07), P = 0.0003 | 68 |
| HDL cholesterol:LDL cholesterol | 3 | 3 | 209 | −0.06 (−0.23, 0.11), P = 0.46 | 53 |
| LDL cholesterol:HDL cholesterol | 39 | 38 | 2539 | −0.14 (−0.20, 0.08), P < 0.00001 | 75 |
| ApoB, mg/dL | 39 | 39 | 3069 | −3.01 (−4.44, −1.58), P < 0.00001 | 44 |
| ApoA-I, mg/dL | 33 | 33 | 2259 | −1.02 (−2.53, 0.49), P = 0.19 | 0 |
| SBP, mmHg | 71 | 70 | 6521 | −0.05 (−0.83, 0.72), P = 0.89 | 47 |
| DBP, mmHg | 67 | 66 | 6198 | −0.10 (−0.53, 0.33), P = 0.65 | 24 |
Abbreviations: ApoA-I, apolipprotein A-1; ApoB, apolipoprotein B; DBP, diastolic blood pressure; HDL, high density lipoprotein; LDL, low density lipoprotein; SBP, systolic blood pressure; TC, total cholesterol; TG, triglycerides.